(b)(4).Rns device implanted on right parietal section of the skull.Two leads: port1, cl-325-10, sn (b)(4), right inferior occipital.Port2, cl-325-10, sn (b)(4), right superior occipital.
|
Neuropace was informed in june 2017 that the patient had reported a blind spot in her visual field.The patient was worked up for visual field testing and the treating physician felt that the visual field changes were not attributable to the rns system; therefore the event was not reported.No changes to responsive stimulation were made at that time.In (b)(6) 2017, the patient was seen by a different physician and at that time responsive stimulation was disabled in order to determine the effectiveness of the rns system on the patient's seizures.While responsive stimulation was disabled, the patient continued to have visual field changes and was subsequently hospitalized.During hospitalization, further diagnostic testing was performed.Responsive stimulation was re-enabled in august and the physician stated that the visual field changes could be attributed to the rns system implant.
|